The otolaryngologic presentation of amyotrophic
This report provides comprehensive information on the therapeutic development for Amyotrophic
Lateral Sclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
The report, the Global Amyotrophic
Lateral Sclerosis Drugs market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.
lateral sclerosis, physical exercise, trauma and sports: Results of a population-based pilot case-control study.
lateral sclerosis: report of a young married couple.
Effect of noninvasive positive-pressure ventilation on survival in amyotrophic
lateral sclerosis (ALS), also known as motor neuron disease or Lou Gehrig's disease, is a rare neuromuscular disease with an incidence rate of about 1 in 100,000.
Edwards is suffering from Amyotrophic
Lateral Sclerosis (ALS), more commonly known as Lou Gehrig's Disease, but he was treating it as an imposter.
A former inmate suffering from amyotrophic
lateral sclerosis (ALS) brought a [section] 1983 action against corrections officials, alleging violations of the Americans with Disabilities Act (ADA).
ExonHit Therapeutics, Paris, France, the alternative splicing- based drug discovery company, has initiated its first clinical trial evaluating EHT 0201 (pentoxifylline) in patients suffering from Amyotrophic
Lateral Sclerosis (ALS).
She had a 14-month history of amyotrophic
Scope The report analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal trends in Alzheimer's Disease (AD), Parkinson's Disease (PD), Amyotrophic
Lateral Sclerosis (ALS) and Huntington's Disease (HD).